Stepwise mitochondria-targeted photodynamic immunotherapy enabled by an outer membrane vesicles-based nanoplatform for synergistic tumor ablation and immune reprogramming

Xiang Cheng , Ziheng Luo , Ying Yin , Duoyang Fan , Ruyan Xie , Yanpeng Fang , Xiaohui Liu , Dayan Xiong , Wei Liu , Seraphine V. Wegner , Fei Chen , Wenbin Zeng

Smart Molecules ›› 2026, Vol. 4 ›› Issue (2) : e70039

PDF (5546KB)
Smart Molecules ›› 2026, Vol. 4 ›› Issue (2) :e70039 DOI: 10.1002/smo2.70039
RESEARCH ARTICLE
Stepwise mitochondria-targeted photodynamic immunotherapy enabled by an outer membrane vesicles-based nanoplatform for synergistic tumor ablation and immune reprogramming
Author information +
History +
PDF (5546KB)

Abstract

Photodynamic immunotherapy (PDIT) integrates reactive oxygen species (ROS)-mediated tumor destruction with immune activation. However, its effectiveness is often hindered by tumor hypoxia, poor tumor-targeted delivery, and the immunosuppressive microenvironment. Here, we introduce BDPM@OMVs, a biomimetic nanoplatform designed to overcome these challenges. This system uses bacterial outer membrane vesicles to encapsulate a novel, heavy-atom-free aggregation-induced emission photosensitizer (BDPM). Our platform enables stepwise lysosome-to-mitochondria trafficking for enhanced PDIT. BDPM@OMVs exhibits strong near-infrared absorption and efficient intersystem crossing, leading to both Type I and Type II ROS generation, which sustains photodynamic performance even under hypoxic conditions. Upon light irradiation, BDPM@OMVs trigger photochemical internalization (PCI), disrupting lysosomes and releasing BDPM into the cytosol. The freed BDPM then selectively accumulates in mitochondria, where continues light exposure generates robust ROS, causing mitochondrial dysfunction and activating apoptosis. This process effectively amplifies tumor cell eradication. Simultaneously, BDPM@OMVs reprogram the tumor immune microenvironment by promoting macrophage repolarization from the immunosuppressive M2 to the pro-inflammatory M1 phenotype, as evidenced by upregulated TNF-α, IL-1β, and CD86 expression. In vivo studies confirm that BDPM@OMVs achieve efficient tumor accumulation, allow for real-time NIR imaging, and provide superior therapeutic outcomes. This work presents a versatile and hypoxia-resilient PDIT strategy that synergistically integrates precise subcellular photodamage with immune modulation to overcome resistance in solid tumors.

Keywords

bacterial outer membrane vesicles / macrophage polarization / photodynamic therapy / photosensitizers

Cite this article

Download citation ▾
Xiang Cheng, Ziheng Luo, Ying Yin, Duoyang Fan, Ruyan Xie, Yanpeng Fang, Xiaohui Liu, Dayan Xiong, Wei Liu, Seraphine V. Wegner, Fei Chen, Wenbin Zeng. Stepwise mitochondria-targeted photodynamic immunotherapy enabled by an outer membrane vesicles-based nanoplatform for synergistic tumor ablation and immune reprogramming. Smart Molecules, 2026, 4 (2) : e70039 DOI:10.1002/smo2.70039

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

J. Nam, S. Son, K. S. Park, W. P. Zou, L. D. Shea, J. J. Moon, Nat. Rev. Mater. 2019, 4, 398.

[2]

K. Palucka, J. Banchereau, Nat. Rev. Cancer 2012, 12, 265.

[3]

J. Yang, B. B. Ren, X. T. Yin, L. L. Xiang, Y. Q. Hua, X. Huang, H. B. Wang, Z. W. Mao, W. Chen, J. Deng, Adv. Mater. 2024, 36, 2402720.

[4]

M. Toyofuku, N. Nomura, L. Eberl, Nat. Rev. Microbiol. 2019, 17, 13.

[5]

C. Schwechheimer, M. J. Kuehn, Nat. Rev. Microbiol. 2015, 13, 605.

[6]

Y. L. Yue, J. Q. Xu, Y. Li, K. M. Cheng, Q. Q. Feng, X. T. Ma, N. N. Ma, T. J. Zhang, X. W. Wang, X. Zhao, G. J. Nie, Nat. Biomed. Eng. 2022, 6, 898.

[7]

R. Palomino, C. Vanpouille, P. E. Costantini, L. Margolis, PLoS Pathog. 2021, 17, 1009508.

[8]

W. R. Zhuang, Y. F. Wang, Y. Lei, L. P. Zuo, A. Q. Jiang, G. H. Wu, W. D. Nie, L. L. Huang, H. Y. Xie, Nano Lett. 2022, 22, 4491.

[9]

S. Qing, C. L. Lyu, L. Zhu, C. Pan, S. Wang, F. Li, J. H. Wang, H. Yue, X. Y. Gao, R. R. Jia, W. Wei, G. H. Ma, Adv. Mater. 2020, 32, 2002085.

[10]

Q. Q. Feng, X. T. Ma, K. M. Cheng, G. N. Liu, Y. Li, Y. L. Yue, J. Liang, L. Z. Zhang, T. J. Zhang, X. W. Wang, X. Y. Gao, G. J. Nie, X. Zhao, Adv. Mater. 2022, 34, 2002085.

[11]

L. L. Chen, X. Ma, W. J. Liu, Q. Q. Hu, H. H. Yang, Nano Lett. 2023, 23, 8725.

[12]

O. Y. Kim, H. T. Park, N. T. H. Dinh, S. J. Choi, J. Lee, J. H. Kim, S. W. Lee, Y. S. Gho, Nat. Commun. 2017, 8, 626.

[13]

K. S. Zheng, Y. P. Feng, L. Li, F. Y. Kong, J. Gao, X. Y. Kong, Theranostics 2024, 14, 761.

[14]

V. Gujrati, S. Kim, S. H. Kim, J. J. Min, H. E. Choy, S. C. Kim, S. Jon, ACS Nano 2014, 8, 1525.

[15]

Q. Long, P. Zheng, X. Zheng, W. R. Li, L. Q. Hua, Z. Q. Yang, W. W. Huang, Y. B. Ma, Adv. Drug Deliv. Rev. 2022, 186, 114321.

[16]

S. Y. Chong, C. K. Lee, C. Y. Huang, Y. H. Ou, C. J. Charles, A. M. Richards, Y. R. Neupane, M. V. Pavon, O. Zharkova, G. Pastorin, J. W. Wang, Int. J. Mol. Sci. 2019, 20, 3272.

[17]

Z. Q. Cong, Y. Y. Li, L. M. Xie, Q. W. Chen, M. H. Tang, P. Thongpon, Y. X. Jiao, S. Wu, Small 2024, 20, 2400847.

[18]

P. C. Lo, M. S. Rodríguez-Morgade, R. K. Pandey, D. K. P. Ng, T. Torres, F. Dumoulin, Chem. Soc. Rev. 2020, 49, 1041.

[19]

T. C. Pham, V. N. Nguyen, Y. Choi, S. Lee, J. Yoon, Chem. Rev. 2021, 121, 13454.

[20]

W. Q. Jiang, M. K. Liang, Q. F. Lei, G. Z. Li, S. Wu, Cancers 2023, 15, 585.

[21]

G. Yang, J. S. Ni, Y. X. Li, M. L. Zha, Y. Tu, K. Li, Angew. Chemie-International Edition 2021, 60, 5386.

[22]

H. Wang, X. Z. Yang, W. Shao, S. C. Chen, J. F. Xie, X. D. Zhang, J. Wang, Y. Xie, J. Am. Chem. Soc. 2015, 137, 11376.

[23]

K. K. Wen, H. Tan, Q. Peng, H. Chen, H. Ma, L. Wang, A. D. Peng, Q. Q. Shi, X. D. Cai, H. Huang, Adv. Mater. 2022, 34, 2108146.

[24]

K. X. Teng, W. K. Chen, L. Y. Niu, W. H. Fang, G. L. Cui, Q. Z. Yang, Angew. Chemie-International Edition 2021, 60, 19912.

[25]

X. S. Li, J. F. Lovell, J. Yoon, X. Y. Chen, Nat. Rev. Clin. Oncol. 2020, 17, 657.

[26]

J. P. Ding, T. Y. Zhu, F. Zheng, F. Gao, S. W. Zhang, K. X. Zhang, J. R. Zeng, J. Dong, W. B. Zeng, Small 2024, 20, 2405164.

[27]

Y. H. Liu, X. Q. Chen, X. T. Liu, W. J. Guan, C. Lu, Chem. Soc. Rev. 2023, 52, 1456.

[28]

Z. Wang, C. Y. Liu, X. S. Zou, W. J. Chi, Y. M. Zhang, X. W. Luo, Y. Z. Xu, J. Liu, N. J. Zhao, W. Zhang, M. Y. Zu, W. P. Yin, L. J. Meng, D. F. Dang, Small 2025, 21, 2411643.

[29]

S. Chakrabortty, B. K. Agrawalla, A. Stumper, N. M. Veg, S. Fischer, C. Reichardt, M. Kögler, B. Dietzek, M. Feuring-Buske, C. Buske, S. Rau, T. Weil, J. Am. Chem. Soc. 2017, 139, 2512.

[30]

J. W. Tian, B. W. Li, F. Zhang, Z. Yao, W. T. Song, Y. F. Tang, Y. Ping, B. Liu, Angew. Chemie-International Edition 2023, 62, e202307288.

[31]

H. Cheng, J. H. Fan, L. P. Zhao, G. L. Fan, R. R. Zheng, X. Z. Qiu, X. Y. Yu, S. Y. Li, X. Z. Zhang, Biomaterials 2019, 211, 14.

[32]

J. C. Li, Y. Luo, K. Y. Pu, Angew. Chemie-International Edition 2021, 60, 12682.

[33]

X. L. Zeng, Z. W. Zhang, Y. S. Huang, J. L. Fan, X. J. Peng, S. Wu, W. Sun, Adv. Funct. Mater. 2024, 34, 2315885.

[34]

X. D. Zhu, C. Huang, Y. H. Shen, Y. Ji, N. L. Ge, X. D. Qu, L. L. Chen, W. K. Shi, M. L. Li, J. J. Zhu, C. J. Tan, Z. Y. Tang, J. Zhou, J. Fan, H. C. Sun, Liver Cancer 2021, 10, 320.

[35]

Y. T. Zhong, Z. T. Qiu, K. Y. Zhang, Z. M. Liu, Z. F. Li, Y. Cen, S. Y. Li, H. C , Adv. Mater. 2025, 37, 2415078.

[36]

M. Y. Yan, X. Y. Chen, X. T. Li, Q. Q. Liu, B. X. Yu, Y. Cen, W. Zhang, Y. B. Liu, X. X. Li, Y. Chen, T. W , S. Y. Li, Acta Pharm. Sin. B 2024, 14, 4118.

[37]

Y. Cen, Y. Chen, X. X. Li, X. Y. Chen, B. X. Yu, M. Y. Yan, N. Yan, H. Chen, S. Y. Li, Biomaterials 2024, 308, 122568.

[38]

A. Turksoy, D. Yildiz, E. U. Akkaya, Coord. Chem. Rev. 2019, 379, 47.

[39]

E. Bassan, A. Gualandi, P. G. Cozzi, P. Ceroni, Chem. Sci. 2021, 12, 6607.

[40]

V. N. Nguyen, Y. Yim, S. Kim, B. Ryu, K. M. K. Swamy, G. Kim, N. Kwon, C. Y. Kim, S. Park, J. Yoon, Angew. Chemie-International Edition 2020, 59, 8957.

[41]

S. Huang, S. G. Bai, T. Luo, F. Zheng, D. Y. Fan, Y. Y. Zhou, J. Dong, F. Chen, W. B. Zeng, Adv. Funct. Mater. 2024, 34, 2409292.

[42]

T. Lu, F. W. Chen, J. Comput. Chem. 2012, 33, 580.

[43]

X. Zhao, R. F. Zhao, G. J. Nie, Nat. Protoc. 2022, 17, 2240.

[44]

M. Z. Zou, Z. H. Li, X. F. Bai, C. J. Liu, X. Z. Zhang, Nano Lett. 2021, 21, 8609.

Rights & permissions

2026 The Author(s). Smart Molecules published by John Wiley & Sons Australia, Ltd on behalf of Dalian University of Technology.

PDF (5546KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉